Loading...
GSK plc
GSK•NYSE
Healthcare
Drug Manufacturers - General
$37.97
$-0.26(-0.68%)
GSK plc (GSK) Financial Performance & Income Statement Overview
Review GSK plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.46%
↑ 3.46%
Operating Income Growth
-40.39%
↓ 40.39%
Net Income Growth
-47.75%
↓ 47.75%
Operating Cash Flow Growth
-3.16%
↓ 3.16%
Operating Margin
16.13%
↑ 16.13%
Gross Margin
71.54%
↑ 71.54%
Net Profit Margin
10.000%
↑ 10.000%
ROE
22.44%
↑ 22.44%
ROIC
12.76%
↑ 12.76%
GSK plc (GSK) Income Statement & Financial Overview
Review GSK plc's (GSK) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $8.12B | $8.01B | $7.88B | $7.36B |
| Cost of Revenue | $2.56B | $2.40B | $2.08B | $1.94B |
| Gross Profit | $5.56B | $5.62B | $5.80B | $5.43B |
| Gross Profit Ratio | $0.68 | $0.70 | $0.74 | $0.74 |
| R&D Expenses | $2.03B | $1.46B | $1.43B | $1.37B |
| SG&A Expenses | $2.66B | $3.80B | $2.39B | $2.07B |
| Operating Expenses | $4.86B | $5.43B | $3.82B | $3.44B |
| Total Costs & Expenses | $7.42B | $7.82B | $5.90B | $5.38B |
| Interest Income | -$51.00M | $32.00M | $24.00M | $32.00M |
| Interest Expense | $144.00M | $156.00M | $174.00M | $166.00M |
| Depreciation & Amortization | $412.00M | $951.00M | $639.00M | $549.00M |
| EBITDA | $1.12B | $1.17B | $2.85B | $2.80B |
| EBITDA Ratio | $0.14 | $0.15 | $0.36 | $0.38 |
| Operating Income | $696.00M | $189.00M | $1.99B | $1.98B |
| Operating Income Ratio | $0.09 | $0.02 | $0.25 | $0.27 |
| Other Income/Expenses (Net) | -$133.00M | -$125.00M | -$151.00M | -$135.00M |
| Income Before Tax | $563.00M | $64.00M | $1.50B | $1.36B |
| Income Before Tax Ratio | $0.07 | $0.008 | $0.19 | $0.18 |
| Income Tax Expense | $62.00M | -$1.00M | $191.00M | $274.00M |
| Net Income | $414.00M | -$58.00M | $1.17B | $1.05B |
| Net Income Ratio | $0.05 | -$0.007 | $0.15 | $0.14 |
| EPS | $0.10 | -$0.01 | $0.29 | $0.26 |
| Diluted EPS | $0.10 | -$0.01 | $0.28 | $0.25 |
| Weighted Avg Shares Outstanding | $4.08B | $4.08B | $4.08B | $4.07B |
| Weighted Avg Shares Outstanding (Diluted) | $4.14B | $4.14B | $4.12B | $4.11B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan